
Data Analysis services

Meta-Analysis Research Services

Data Collection Services

Statistical Programming & Biostatistics services

Data Management Services

Research methodology services

Tool development services
Statistical Interpretation services

Statistical Interpretation services
Sample Size Calculation Services

Sample Size Calculation Services
Artificial Intelligence and Machine Learning Services

Artificial Intelligence and Machine Learning Services
Report generation Service

Report generation Services

Data Analysis services

Meta-Analysis Research Services

Data Collection Services

Statistical Programming & Biostatistics services

Data Management Services

Research methodology services

Tool development services
Statistical Interpretation services

Statistical Interpretation services
Sample Size Calculation Services

Sample Size Calculation Services
Artificial Intelligence and Machine Learning Services

Artificial Intelligence and Machine Learning Services
Report generation Service

Report generation Services
Summary:
This blog post aims to analyze SAS, Python, and R as the most popular statistical programming languages used in the field of biometrics in 2026. Thus, the benefits of using each of these software products for analytical and regulatory submission processes, conducting clinical trials and analysis, applying machine learning, complying with CDISC standards, and performing research have been discussed. In addition, the tendency of hybrid programming, including the use of all three languages, has been described.
Medical device biometrics analytics programming languages are dominated by a triumvirate of statistical programming languages which account for 95% of all FDA submissions, clinical trials, and regulatory submissions made globally. Identifying the statistical programming languages which dominate the industry, and the reasons for their prevalence, is an important consideration for biostatisticians, data scientists, and entities which are involved in clinical trial data analysis services.
The statistical programming landscape in medical device biometrics has undergone significant change. The industry trends have seen a rise in the use of statistical programming solutions:
Most companies are leveraging multiple languages for statistical programming and analysis to meet diverse needs of regulatory submission while being able to take advantage of the advanced statistical capabilities and performance of different programming tools [1].
SAS offers the most popular software among FDA’s regulatory statistical programming. The company’s products hold the biggest share in the market for medical device biometrics analytics due to more than 40 years of proven software development experience and regulatory approval.
Why SAS Leads:
SAS programs produce around 65% of all the FDA-submitted biometrics datasets; organizations that outsource big volumes of biostatistics work rely on SAS to meet the regulatory requirements.
Large pharmaceutical companies have on average 3-5 SAS programmers per clinical trial program. Mostly used procedures are PROC REPORT, PROC MEANS and PROC SQL for clinical trial data analysis, while for medical device biometrics the most used procedure is PROC GENMOD for complex statistical analysis [3].
Python’s use in medical device biometrics is becoming more rapid, given the growing need for AI in clinical biostatistics and the need to process data in real-time. Some current biostatistics outsourcing companies are now using the software for such high-intensity applications.
Python programming is adopted by pioneering firms for preparing data, carrying out the analysis process, building artificial intelligence algorithms, and validation of the outcomes in SAS to adhere to regulations [4]. Python programming and SAS are becoming increasingly popular in the industry.
R is dominant in the academic, research, and clinical biostatistics communities, where it is often used for innovative statistical research. Although less common than SAS in commercial FDA submissions, R offers unparalleled statistical power.
The most sophisticated organizations now employ multi-language ecosystems:
This well-coordinated strategy ensures both compliance and efficacy, exemplifying the future of outsourced enterprise biostatistics in 2026.
Our certified biostatisticians can assist you in all three platforms. They have the expertise of utilizing all statistical programming languages and processes according to the specific regulatory requirements. Thus, if you are working on any project be it medical device biometrics, clinical trial or research, our experts can help you with SAS, Python or R language or any other.
🎯 Get Your Free Technical Assessment
Schedule a consultation with Statswork’s biostatisticians. We’ll evaluate your statistical programming requirements, recommend the optimal language strategy, and outline how our clinical trial data analysis services accelerate regulatory success.
Contact Statswork Today — Statistical Precision Meets Regulatory Excellence
Yes, R remains highly relevant for statistical analysis, research, and biostatistics.
It is widely used for advanced statistical modelling and data visualization.
R can be easier for statistical tasks, while Python is more versatile for general programming.
The difficulty depends on your background and learning goals.
No, you do not need to learn R before Python.
Choose R for statistics and research, or Python for AI, automation, and broader programming.
Yes, you can build a strong foundation in R within three months with regular practice.
You can learn data manipulation, visualization, and basic statistical analysis.
No, R is not a dying language and remains important in statistics, research, and biostatistics.
Its specialized statistical capabilities continue to support its use.
Neither language is universally faster because performance depends on the task and implementation.
Python can be faster for some large-scale applications, while R performs well for many statistical operations.
WhatsApp us